Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes.

Naïve DME eyes received lower number of IDI injections and showed better VA levels than PT DME eyes for 24 months in a real-world setting. This data supports the IDI use in early DME stages and provide further evidence of better IDI response when used as first-line therapy.